Fu Chen-Fei, Li Jian-Long, Chen Jia-Wei, Liang Hao, Zhao Wen-Rui, He Shi-Yu, Ma Xiao-Wei, Yang Xiao-Fan, Wang He-Lin
Heilongjiang University of Chinese Medicine, Harbin, China.
Liaoning Normal University, Dalian, China.
Front Pharmacol. 2024 Jul 3;15:1365639. doi: 10.3389/fphar.2024.1365639. eCollection 2024.
Sepsis is a complex syndrome characterized by multi-organ dysfunction, due to the presence of harmful microorganisms in blood which could cause mortality. Complications associated with sepsis involve multiple organ dysfunction. The pathogenesis of sepsis remains intricate, with limited treatment options and high mortality rates. Traditional Chinese medicine (TCM) has consistently demonstrated to have a potential on various disease management. Its complements include reduction of oxidative stress, inhibiting inflammatory pathways, regulating immune responses, and improving microcirculation. Traditional Chinese medicine can mitigate or even treat sepsis in a human system. This review examines progress on the use of TCM extracts for treating sepsis through different pharmacological action and its mechanisms. The potential targets of TCM extracts and active ingredients for the treatment of sepsis and its complications have been elucidated through molecular biology research, network pharmacology prediction, molecular docking analysis, and visualization analysis. Our aim is to provide a theoretical basis and empirical support for utilizing TCM in the treatment of sepsis and its complications while also serving as a reference for future research and development of sepsis drugs.
脓毒症是一种以多器官功能障碍为特征的复杂综合征,其病因是血液中存在有害微生物,可导致死亡。与脓毒症相关的并发症包括多器官功能障碍。脓毒症的发病机制仍然错综复杂,治疗选择有限且死亡率高。传统中医(TCM)在各种疾病管理中一直显示出具有潜力。其作用包括减轻氧化应激、抑制炎症途径、调节免疫反应和改善微循环。传统中医可以在人体系统中减轻甚至治疗脓毒症。本综述探讨了通过不同药理作用及其机制使用中药提取物治疗脓毒症的进展。通过分子生物学研究、网络药理学预测、分子对接分析和可视化分析,阐明了中药提取物和活性成分治疗脓毒症及其并发症的潜在靶点。我们的目的是为利用传统中医治疗脓毒症及其并发症提供理论依据和实证支持,同时也为脓毒症药物的未来研发提供参考。
Front Pharmacol. 2024-7-3
Front Pharmacol. 2023-1-19
BMC Complement Med Ther. 2023-2-10
Zhongguo Zhong Yao Za Zhi. 2023-9
Comb Chem High Throughput Screen. 2024
J Clin Med. 2023-2-6
Oxid Med Cell Longev. 2023
Front Pharmacol. 2023-1-19
Acta Pharm Sin B. 2022-12
Cell Death Differ. 2023-2